Virtual ISPOR Europe from 16.11 until 19.11.
Improving Health: Establishing Incentives and Sharing Value - our posters on different aspects of AMNOG & market access are online now!
The ISPOR (International Society for Pharmacoeconomics and Outcomes Research) is the leading professional society for health economics and outcomes research (HEOR) globally. In addition to a variety of educational programs, ISPOR organizes annual regional conferences in Asia, Europe, Latin America and the USA, which provide a platform for professional and methodological exchange within the HEOR community.
Due to the COVID-19 pandemic, this year's ISPOR Europe will not take place in Milan as planned. Instead, it will be held virtually from the 16th to the 19th of November. The main topic this year is Improving Health: Establishing Incentives and Sharing Value. SKC will again be present with a variety of posters on different aspects of market access, which can be viewed in the interactive poster gallery before and during the conference.
We would be delighted if you would visit us in the gallery at the times indicated below. We are very interested in hearing your valued feedback and to discuss our poster contributions in more detail. Furthemore, please feel free to contact us via e-mail, which can be sent directly to the respective authors in the poster gallery.
SKC's Poster Gallery:
- Paying for Curative Gene Therapies: Potential, Barriers and Healthcare Reforms for Risk-Sharing between Payers and Industry in a MULTI-Payer Healthcare System, Ruedemann N, Florian M, Schoenermark MP, ID: 106027, CODE: PBI34, present in the online gallery: 18.11. from 3:00 - 4:30 PM
- With One′s back to the Wall – "How to convince the G-BA of an Added Benefit if the IQWiG is against You?", Hantke I, Schoenermark MP, ID: 105842, CODE: PDG64, present in the online gallery: 16.11. from 4:30 – 5:30 PM
- Outcomes of Benefit Reassessments of Orphan Drugs in Germany after Exceedance of the 50-Million-EURO Revenue Threshold, Frick L, Kleinesudeik L, Johannssen T, Schoenermark MP, ID: 107649, CODE: PRO94, present in the online gallery: 16.11. from 4:30 - 6:00 PM
- Outcomes of Benefit Reassessments of Medicinal Products in Germany after Expiry of the Limitation of G-BA Resolution, Kleinesudeik L, Frick L, Johannssen T, Schoenermark MP, ID: 107695, CODE: PDG62, present in online gallery: 16.11. from 4:30 - 5:30 PM
- Risk Factors for NOVEL Pharmaceutical Products of Being Imposed with a Registry during the German Benefit Assessment, Buchholz I, Ruedemann N, Frick L, Schoenermark MP, ID: 107898, CODE: PRO104, present in online gallery: 18.11. 3:00 - 4:30 PM
- Analysis of the EARLY Benefit Assessment in the Indication NSCLC in Germany – Which Factors Affect the Price?, Kenfack E, Buchholz I, Presuhn F, Schoenermark MP, ID: 107654, CODE: PCN206, present in the online gallery: 16.11. from 4:30 - 6:00 PM
- When the German Healthcare System Seems Overwhelmed - Performance of the MOST Expensive Pharmaceuticals in the German HTA (AMNOG)-Procedure, Kenfack E, Presuhn F, Schoenermark MP, ID: 108021, CODE: PMU10, present in online gallery: 16.11. from 4:30 - 6:00 PM
With the main theme of this year's conference being innovation and shared value in health care, investment and innovation in regards to personalized medicine and rare diseases as well as their sustainability, SKC is looking forward to lively discussions with the global HEOR community and to gaining inspiring and innovative insights for future activities.
